Bacteriophages
(phages) are an underutilized biological resource
with vast potential for pathogen control and microbiome editing. Phage
research and commercialization have increased rapidly in biomedical
and agricultural industries, but adoption has been limited elsewhere.
Nevertheless, converging advances in DNA sequencing, bioinformatics,
microbial ecology, and synthetic biology are now poised to broaden
phage applications beyond pathogen control toward the manipulation
of microbial communities for defined functional improvements. Enhancements
in sequencing combined with network analysis make it now feasible
to identify and disrupt microbial associations to elicit desirable
shifts in community structure or function, indirectly modulate species
abundance, and target hub or keystone species to achieve broad functional
shifts. Sequencing and bioinformatic advancements are also facilitating
the use of temperate phages for safe gene delivery applications. Finally,
integration of synthetic biology stands to create novel phage chassis
and modular genetic components. While some fundamental, regulatory,
and commercialization barriers to widespread phage use remain, many
major challenges that have impeded the field now have workable solutions.
Thus, a new dawn for phage-based (chemical-free) precise biocontrol
and microbiome editing is on the horizon to enhance, suppress, or
modulate microbial activities important for public health, food security,
and more sustainable energy production and water reuse.